Matters

  • Advised a private equity sponsor in the acquisition of a multi-state ABA platform; identified reimbursement and credentialing considerations that informed valuation, escrow structure, and post-closing integration strategy.
  • Served as lead healthcare regulatory counsel in the sale of one of the largest medical oncology practices in the United States.
  • Led diligence for a specialty pharmacy platform, evaluating infusion and compounding reimbursement models across Medicare and multiple payor requirements; findings informed transaction structure and growth assumptions.
  • Counseled multiple national diagnostic laboratories on coverage and payment considerations, including coding and billing practices.
  • Represented numerous healthcare providers in responding to government audit and reimbursement-related claims, including Federal False Claims Act matters, mitigating financial exposure and operational disruption.
  • Advised investors and operators on Medicare and Medicaid reimbursement strategies tied to expansion into new states, including licensure and corporate practice of medicine considerations.
  • Structured reimbursement and compliance frameworks for platform roll-up strategies in behavioral health and ancillary services sectors.
  • Assisted healthcare providers in resolving complex payment disputes with CMS, Medicare contractors, and commercial payors affecting ongoing revenue streams.